WeDaita · Platform Overview
BioMedAI: AI Target Discovery
to AI Drug Design
Agentic AI for Target Discovery and Therapeutic Design — one platform, from a single research question to optimized drug candidates.
Engine 1 · Immediate focus
AI Target Discovery — the right target, decided with confidence
Target identification and validation in one platform.
Public data
Provides breadth- Scientific literature
- Public databases
- Clinical studies
- Open datasets
Integrate · Connect · Reason
Target Intelligence
Engine
AI + Knowledge Graphs + Domain ModelsEngine
In minutes
Private data
Provides context- Internal research & experimental data
- Organizational knowledge
- Expertise & experience
- Proprietary datasets
Insights
➜Better decisions
➜Better outcomes
Target A · High confidence92 / 100
Target B · Moderate78 / 100
Target C · Exploratory64 / 100
CLINAVA™ clinical progression prediction
GENAVA™ virtual-cell target validation
Illustrative scorecard values.
Engine 2 · Bridging targets to therapeutics
AI Drug Design — turning promising targets into viable therapeutics
Connecting target intelligence directly to therapeutic design.
Target & pocket data
Provides structural context- Selected target profiles
- 3D protein pocket geometry
- Binding mechanism inputs
- Modality constraints
Design · Predict · Optimize
Drug Intelligence
Engine
Predictive, multi-modality AIEngine
Generative models
Provides design capabilities- Small molecule design
- Antibody & protein engineering
- Peptide & macrocycle design
- In silico ADMET & safety scoring
Multi-modality leads
➜Predictive optimization
➜Lab-ready candidates
Why BioMedAI
Built Different — End-to-End by Design
Integrated Pipeline, Not Point Solutions
Most AI drug discovery tools solve one step in isolation. BioMedAI is designed so each stage feeds the next — your research intelligence compounds across stages.
Explainable & Audit-Ready
Every hypothesis, candidate, and output is traceable to its source evidence. BioMedAI doesn't just give answers — it shows its work, suitable for regulatory review.
Human-in-the-Loop by Design
AI generates, scientists decide. BioMedAI's agent workflow has built-in review checkpoints so your team stays in control of every key decision.
40+ Databases, Unified
PubMed, UniProt, ChEMBL, ClinicalTrials.gov, Open Targets and more, plus 300+ domain tools and your private data — queried together and synthesized into structured intelligence, not raw search results.
Speed That Compounds
Target candidate scorecards in minutes instead of 3–4 weeks of manual literature screening. As AI Drug Design and Lab & Clinical Validation come online, that speed advantage extends across the full discovery timeline.
Biopharma-Grade Security
Built with enterprise security requirements in mind — data isolation, access controls, and audit logging for regulated environments.
Start with AI Target Discovery — Live Today
Target scorecards in minutes, not weeks. See how AI Target Discovery works on a real target.